Skip to main content
. 2020 Nov 25;7:601206. doi: 10.3389/fmolb.2020.601206

Figure 6.

Figure 6

Alteration frequency of CXCRs and their correlation with overall survival (OS) and progression-free survival (PFS) of ccRCC patients. (A) The CXCRs mutation rate was 23.14% (118/510) in ccRCC patients. The top four highest mutation rates for CXCR family members were present in CXCR6 (10%), CXCR7 (CXCR7 is also called ACKR3, 7%), CXCR3 (6%), CXCR4 (6%), respectively. (B) Genetic alterations in CXCRs were significantly associated with OS of ccRCC patients (p < 0.05). (C) Genetic alterations in CXCRs were significantly related to PFS of ccRCC patients (P < 0.01).